Evidence map›Paper›PMID 27789942›Full record

ArticleInternational journal of nanomedicine

Comparison of cellular effects of starch-coated SPIONs and poly(lactic-co-glycolic acid) matrix nanoparticles on human monocytes.

Dominik Gonnissen, Ying Qu, Klaus Langer, Cengiz Öztürk, Yuliang Zhao, Chunying Chen, Guiscard Seebohm, Martina Düfer, Harald Fuchs, Hans-Joachim Galla and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of nanomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Immunotoxicity Considerations for Next Generation Cancer Nanomedicines.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Dominik GonnissenCenter for Nanotechnology, Institute of Physics, University of Münster, Münster, Germany.
Ying QuCenter for Nanotechnology, Institute of Physics, University of Münster, Münster, Germany; National Center for Nanoscience and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China.
Klaus LangerInstitute of Pharmaceutical Technology and Biopharmacy, University of Münster, Münster.
Cengiz Öztürkchemicell GmbH, Berlin.
Yuliang ZhaoNational Center for Nanoscience and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China.
Chunying ChenNational Center for Nanoscience and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China.
Guiscard SeebohmDepartment of Cardiovascular Medicine, Institute for Genetics of Heart Diseases, University Hospital Münster.
Martina DüferDepartment of Pharmacology, Institute of Pharmaceutical and Medicinal Chemistry.
Harald FuchsCenter for Nanotechnology, Institute of Physics, University of Münster, Münster, Germany.
Hans-Joachim GallaDepartment of Cell Biology/Biophysics, Institute of Biochemistry, University of Münster, Münster, Germany.
Kristina RiehemannCenter for Nanotechnology, Institute of Physics, University of Münster, Münster, Germany.
CeNTech · DEUniversity of Münster · DENational Center for Nanoscience and Technology · CNChemetall (Germany) · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Within the last years, progress has been made in the knowledge of the properties of medically used nanoparticles and their toxic effects, but still, little is known about their influence on cellular processes of immune cells. The aim of our comparative study was to present the influence of two different nanoparticle types on subcellular processes of primary monocytes and the leukemic monocyte cell line MM6. We used core-shell starch-coated superparamagnetic iron oxide nanoparticles (SPIONs) and matrix poly(lactic-co-glycolic acid) (PLGA) nanoparticles for our experiments. In addition to typical biocompatibility testing like the detection of necrosis or secretion of interleukins (ILs), we investigated the impact of these nanoparticles on the actin cytoskeleton and the two voltage-gated potassium channels Kv1.3 and Kv7.1. Induction of necrosis was not seen for PLGA nanoparticles and SPIONs in primary monocytes and MM6 cells. Likewise, no alteration in secretion of IL-1β and IL-10 was detected under the same experimental conditions. In contrast, IL-6 secretion was exclusively downregulated in primary monocytes after contact with both nanoparticles. Two-electrode voltage clamp experiments revealed that both nanoparticles reduce currents of the aforementioned potassium channels. The two nanoparticles differed significantly in their impact on the actin cytoskeleton, demonstrated via atomic force microscopy elasticity measurement and phalloidin staining. While SPIONs led to the disruption of the respective cytoskeleton, PLGA did not show any influence in both experimental setups. The difference in the effects on ion channels and the actin cytoskeleton suggests that nanoparticles affect these subcellular components via different pathways. Our data indicate that the alteration of the cytoskeleton and the effect on ion channels are new parameters that describe the influence of nanoparticles on cells. The results are highly relevant for medical application and further evaluation of nanomaterial biosafety.

Indexed as

Biocompatible MaterialsCell Line, TumorFerric CompoundsHumansInterleukin-6Lactic AcidMonocytesNanoparticlesPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerStarchBiocompatible MaterialsFerric Compoundsferric oxideInterleukin-6Lactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerStarchactin cytoskeletonAFMcell elasticityion channelspatch clampTEVC

Identifiers

PMID27789942
PMCPMC5072557
OpenAlexW2530319447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.